Cough, Cold & Flu Demand In Community Pharmacy Stabilizes German OTC Market
Executive Summary
German consumers return to bricks-and-mortar pharmacies for advice about OTC cough, cold and flu medicines, which has stabilized this important European consumer healthcare market, according to the latest data from Sempora Consulting.
You may also be interested in...
'Tectonic' Shifts In Germany’s OTC Market Require Smart Sales Strategies
Data from Sempora Consulting shows Germany's OTC market is still struggling to return to pre-pandemic growth levels in the first quarter of 2022. Digging deeper into recent trends like e-commerce and inflationary pricing, the firm suggests a number of points for consumer healthcare companies to consider in formulating their sales strategies for the rest of the year.
UK FSA Finalizes Public CBD List Comprising Almost 12,000 Products
The UK Food Standards Agency has published the final update to its public CBD list following what Canna Consultants' Matt Lawson describes as a regulatory “baptism of fire.” There are now 11,908 products permitted to remain on the UK market once those classed as “removed” are taken into account. These products will either progress to the “validated” stage of the UK's novel food process or also be removed.
Digital Home-Testing Is The Future, Says Bloom Diagnostics Co-Founder Angelica Kohlmann
With its lateral flow at-home tests for ferritin, thyroid function and ovarian reserves, Swiss medtech firm Bloom Diagnostics thinks it has seen the future of consumer healthcare. HBW Insight speaks to co-founder and board chair Angelica Kohlmann about the firm's Bloom Lab technology and forward-looking plans, including a possible US launch.